M&As this week: Court Square Capital Partners, Quotient Sciences Limited, Jinzi Ham

17th November 2017 (Last Updated November 17th, 2017 00:00)

Court Square Capital Partners has acquired a majority stake in clinical research organisation Celerion Holdings from MTS Health Investors.

Court Square Capital Partners has acquired a majority stake in clinical research organisation Celerion Holdings from MTS Health Investors.

Both Court Square and MTS Health are private equity firms.

All the entities involved in the acquisition are based in the US.

Quotient Sciences has acquired contract development and manufacturing organisation Pharmaterials.

This acquisition enables the drug development services organisation to expand its services in the UK.

Both Quotient Sciences and Pharmaterials are based in the US.

"PhoenixBio plans to acquire Canadian in-vivo research services provider KMT Hepatech for C$5.5m ($4.33m)."

Jinzi Ham plans to acquire a 37.14% stake in NovaBay Pharmaceuticals for $27.06m.

Jinzi Ham is a Chinese food production company, whereas NovaBay Pharmaceuticals is a US-based biopharmaceutical company.

PhoenixBio plans to acquire Canadian in-vivo research services provider KMT Hepatech for C$5.5m ($4.33m).

KMT Hepatech will become a subsidiary of the Japanese life-science company upon completion of the acquisition.

Arlington Capital Partners has acquired a majority stake in contract, development, and manufacturing organisation Grand River Aseptic Manufacturing (GRAM).

Both the companies involved are based in the US.